tiprankstipranks
Trending News
More News >
Ekso Bionics Holding (EKSO)
:EKSO
Advertisement

EKSO BIONICS (EKSO) Stock Statistics & Valuation Metrics

Compare
634 Followers

Total Valuation

EKSO BIONICS has a market cap or net worth of $8.49M. The enterprise value is $7.32M.
Market Cap$8.49M
Enterprise Value$7.32M

Share Statistics

EKSO BIONICS has 2,611,788 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,611,788
Owned by Insiders6.10%
Owned by Institutions7.48%

Financial Efficiency

EKSO BIONICS’s return on equity (ROE) is -0.89 and return on invested capital (ROIC) is -50.31%.
Return on Equity (ROE)-0.89
Return on Assets (ROA)-0.43
Return on Invested Capital (ROIC)-50.31%
Return on Capital Employed (ROCE)-0.55
Revenue Per Employee293.85K
Profits Per Employee-185.74K
Employee Count61
Asset Turnover0.67
Inventory Turnover1.84

Valuation Ratios

The current PE Ratio of EKSO BIONICS is ―. EKSO BIONICS’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio0.00
Price to Fair Value14.52
Price to FCF0.00
Price to Operating Cash Flow-0.85
PEG Ratio

Income Statement

In the last 12 months, EKSO BIONICS had revenue of 17.93M and earned -11.33M in profits. Earnings per share was -0.56.
Revenue17.93M
Gross Profit9.51M
Operating Income-10.46M
Pretax Income-11.33M
Net Income-11.33M
EBITDA-9.45M
Earnings Per Share (EPS)-0.56

Cash Flow

In the last 12 months, operating cash flow was -15.79M and capital expenditures -1.53M, giving a free cash flow of -17.33M billion.
Operating Cash Flow-15.79M
Free Cash Flow-17.33M
Free Cash Flow per Share-6.63

Dividends & Yields

EKSO BIONICS pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.85
52-Week Price Change-78.95%
50-Day Moving Average3.75
200-Day Moving Average7.51
Relative Strength Index (RSI)40.46
Average Volume (3m)135.11K

Important Dates

EKSO BIONICS upcoming earnings date is Oct 30, 2025, After Close (Confirmed).
Last Earnings DateJul 28, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend Date

Financial Position

EKSO BIONICS as a current ratio of 2.50, with Debt / Equity ratio of 49.32%
Current Ratio2.50
Quick Ratio1.89
Debt to Market Cap0.03
Net Debt to EBITDA0.05
Interest Coverage Ratio-38.88

Taxes

In the past 12 months, EKSO BIONICS has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

EKSO BIONICS EV to EBITDA ratio is -19.46, with an EV/FCF ratio of -18.61.
EV to Sales10.26
EV to EBITDA-19.46
EV to Free Cash Flow-18.61
EV to Operating Cash Flow-18.68

Balance Sheet

EKSO BIONICS has $0.00 in cash and marketable securities with $5.39M in debt, giving a net cash position of $5.39M billion.
Cash & Marketable Securities$0.00
Total Debt$5.39M
Net Cash$5.39M
Net Cash Per Share$2.06
Tangible Book Value Per Share$0.38

Margins

Gross margin is 51.52%, with operating margin of -58.35%, and net profit margin of -63.21%.
Gross Margin51.52%
Operating Margin-58.35%
Pretax Margin-63.21%
Net Profit Margin-63.21%
EBITDA Margin-52.74%
EBIT Margin-61.71%

Analyst Forecast

The average price target for EKSO BIONICS is $6.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.75
Price Target Upside114.97% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-19.32%
EPS Growth Forecast44.73%

Scores

Smart ScoreN/A
AI Score48.25
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis